Value proposition

Our medical device BraiN20 adresses the best management of Acute Ischemic Stroke
| Neurology | Stroke | MedTech start-up

AFTER A STROKE, TIME LOST IS BRAIN LOST​
1.9M BRAIN CELLS DIE IN 1 MIN​

•The burden of the disease​
15 million people suffer from stroke worldwide each year. ​
1st cause of acquired disability​
2nd leading cause of death​

•Why? The ineffective Acute Ischemic Stroke (AIS) management​

•Our solution​: BraiN20®
A novel portable medical device​
The stroke ECG​

•Our key innovations​
Proprietary algorithm based in TiB research in real patients​
Taylored design and development adjusted to end-users requirements​

​•Our benefits ​
Increasing patients candidates for Endovascular Treatment (EVT)​
Reducing time-to-treatment​
Improving the outcome of EVT

•Board of Directors: Alicia Martínez, Antoni Dávalos, Jaume Coll, Ángel Cánovas, Olivier Resnik, Raúl Zurita (observer), Laurent Arens (observer)

•Contact: aliciamp@tibtimeisbrain.com



Acute Ischemic Stroke, AIS, Portable Medical Device, Medical Device, Mechanical Thrombectomy, MT, N20, Stroke, BraiN20, AIS Diagnosis, AIS Prognosis, AIS Treatment, AIS Patients, N20 Signals, and Healthcare